Merck inaugurates M Lab collaboration centre in Korea

Merck inaugurates M Lab collaboration centre in Korea

6:50 AM, 6th October 2016
Merck inaugurates M Lab collaboration centre in Korea
Newly inaugurated Merck M Lab™ collaboration centre in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.

INCHEON, SOUTH KOREA: Merck inaugurated the M Lab™ collaboration centre in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia. Biopharmaceutical manufacturers will be able to explore new ways to increase productivity, improve processes and mitigate risks. The new centre will include a simulated manufacturing environment and offer full end-to-end process development support.

The inauguration ceremony was attended by Stephan Auer (German ambassador), prof Dr Gerhard Sabathil (ambassador & head of delegation of the European Union to the Republic of Korea), Seung Tack Park (director general for investment policy, ministry of trade, industry and energy), Dr Jeong Bok Yoo (mayor of Incheon Metropolitan City), Young Geun Lee (commissioner, Incheon City government), Dr Frank Stangenberg-Haverkamp (chairman, executive board and the family board, E Merck KG) and Dr Batra.

“With a rapidly growing biopharmaceutical industry in Korea and demand for novel and cost effective therapies worldwide, there is a clear need for innovative concepts like our M Lab collaboration centres,” said Udit Batra, member of the Merck executive board and CEO, life science. “At our new centre, customers will get support to develop processes for manufacturing drugs faster, safer and more effectively than ever before.”

1,865 square metre of space and more than ten highly trained scientists and engineers, the M Lab™ Collaboration Center will serve local biopharma manufacturers, spanning the spectrum from multinational organizations like Samsung Biologics to emerging companies developing biologics to treat rare diseases or different types of cancer.

“Merck’s decision to invest in Songdo, fast growing as world largest biologics manufacturing hub with 520 KL of plant capacity by 2018, represents a significant milestone in the development of the Songdo Bio Cluster,” said T H Kim, CEO, Samsung BioLogics.

© Worldofchemicals news 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

The Nobel Prize 2016 in Chemistry awarded for developing molecular machines

STOCKHOLM, SWEDEN: The Nobel Prize 2016 in Chemistry is finally revealed. The Royal Swedish Academy of Sciences has decided to award the Nobel Prize i ...

Read more
Global market report for industrial control systems security

The global ICS security market will grow at an impressive CAGR of around percent over the predicted period. This market research report presents a de ...

Read more
Henkel contributes computers to a school in Yamahatsu, Thailand

YAMAHATSU, THAILAND: Henkel AG & Company said that its employees from the beauty care plant in Yamahatsu, Thailand visited the Ban Pa Por Sahapatt ...

Read more
Market analysis and forecasts for epoxy resins

Increasing paints & coatings demand due to a positive construction and automotive industries outlook has developed global epoxy resins indust ...

Read more
Ingevity introduces new emulsifiers for drilling fluids

NORTH CHARLESTON, US: Ingevity Corporation has announced the introduction of its new EnvaMul emulsifier product line. Based on fatty acid chemistry, E ...

Read more
Wacker to launch 2 silicone elastomers for encapsulating LEDs

MUNICH, GERMANY: Wacker Chemie AG to launch two new encapsulation compounds for light-emitting diodes (LED). The encapsulants LUMISIL740 and LUMISIL77 ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X